CN1844110B - 高光学纯度的缬沙坦的合成方法 - Google Patents
高光学纯度的缬沙坦的合成方法 Download PDFInfo
- Publication number
- CN1844110B CN1844110B CN200510130401XA CN200510130401A CN1844110B CN 1844110 B CN1844110 B CN 1844110B CN 200510130401X A CN200510130401X A CN 200510130401XA CN 200510130401 A CN200510130401 A CN 200510130401A CN 1844110 B CN1844110 B CN 1844110B
- Authority
- CN
- China
- Prior art keywords
- tetrazole
- methyl
- protecting group
- xie ansuan
- phenylbenzene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510130401XA CN1844110B (zh) | 2005-12-09 | 2005-12-09 | 高光学纯度的缬沙坦的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510130401XA CN1844110B (zh) | 2005-12-09 | 2005-12-09 | 高光学纯度的缬沙坦的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1844110A CN1844110A (zh) | 2006-10-11 |
CN1844110B true CN1844110B (zh) | 2010-07-14 |
Family
ID=37063081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200510130401XA Active CN1844110B (zh) | 2005-12-09 | 2005-12-09 | 高光学纯度的缬沙坦的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1844110B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102010381B (zh) * | 2009-09-05 | 2012-02-08 | 山东新时代药业有限公司 | 一种缬沙坦制备方法的改进 |
AU2011287616A1 (en) * | 2010-08-03 | 2013-02-28 | Novartis Ag | Highly crystalline valsartan |
CN102093302B (zh) * | 2011-01-28 | 2013-03-20 | 海南美兰史克制药有限公司 | 缬沙坦化合物及其制法 |
CN102351804B (zh) * | 2011-09-30 | 2013-07-31 | 浙江新赛科药业有限公司 | 一种缬沙坦消旋体的回收方法 |
CN102863398B (zh) * | 2012-09-29 | 2015-03-25 | 苏州天绿生物制药有限公司 | 一种沙坦类药物中间体的合成方法以及该中间体的应用 |
CN103554047A (zh) * | 2013-10-11 | 2014-02-05 | 镇江市高等专科学校 | 制备缬沙坦的方法 |
CN104072433A (zh) * | 2014-07-16 | 2014-10-01 | 南京正大天晴制药有限公司 | 一种缬沙坦的水解杂质化合物及其制备方法、检测方法和用途 |
CN104151199A (zh) * | 2014-08-13 | 2014-11-19 | 苏州卫生职业技术学院 | 一种缬沙坦的合成方法 |
-
2005
- 2005-12-09 CN CN200510130401XA patent/CN1844110B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN1844110A (zh) | 2006-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1844110B (zh) | 高光学纯度的缬沙坦的合成方法 | |
CN114555556B (zh) | 制备cftr调节剂的方法 | |
US7067669B2 (en) | Substantially pure cilostazol and processes for making same | |
CN106316889B (zh) | 依度沙班中间体的制备方法 | |
WO1999001420A1 (fr) | Procede de preparation de derives d'acide 2-aminomalonique, et intermediaires utilises dans ce procede | |
CN102307866A (zh) | 一种利奈唑胺的制备方法及其中间体 | |
CN100522953C (zh) | 一种缬沙坦的新合成方法 | |
WO2012025944A2 (en) | Sitagliptin, salts and polymorphs thereof | |
CN101410374A (zh) | 用于制备盐酸多奈哌齐的中间体和其新多晶型物的改良的合成和制备 | |
CN100344625C (zh) | 一种制备坎地沙坦的方法 | |
CN101935308A (zh) | 一种合成缬沙坦的新方法 | |
CN109761924A (zh) | 一种改进的缬沙坦反应混合液的后处理方法 | |
WO2004062571A2 (en) | Substantially pure cilostazol and processes for making same | |
US20100010221A1 (en) | Processes for purifying varenicline l-tartrate salt and preparing crystalline forms of varenicline l-tartrate salt | |
CN107531636A (zh) | 茚达特罗或其盐的制备方法 | |
US9403785B2 (en) | Process for preparing amorphous cabazitaxel | |
JP2009531419A (ja) | キノロン中間体を調製するための水素化物還元法 | |
CN103922986B (zh) | 维大列汀及其类似物、中间体及其制备方法和应用 | |
WO2014051077A1 (ja) | 高純度の含窒素複素環化合物の製造方法 | |
CN107406371A (zh) | 3‑苯基异丝氨酸衍生物的制造方法 | |
ES2288376B1 (es) | Procedimiento para la obtencion de intermedios utiles en la obtencion de un compuesto farmaceuticamente activo. | |
CN115260116B (zh) | 8-(2-羟基苯甲酰胺基)辛酸钠及苯并噁嗪-2,4-二酮和8-溴辛酸乙酯的制法 | |
CN103288813A (zh) | 一种阿瑞匹坦的制备方法 | |
JP7090645B2 (ja) | イオシメノールの製造方法 | |
CN104292130B (zh) | 一种波普瑞韦中间体2-羟基-3-氨基-4-环丁基丁酰胺盐酸盐的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 318020 Jiangkou Development Zone, Taizhou, Zhejiang, Huangyan Patentee after: Zhejiang Tianyu Pharmaceutical Co., Ltd. Address before: 318020 Jiangkou Development Zone, Taizhou, Zhejiang, Huangyan Patentee before: Zhejiang Tianyu Pharmaceutical Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180620 Address after: 317000 Taizhou chemical raw material base, Zhejiang, Taizhou, 15 Patentee after: Linhai Tianyu Pharmaceutical Co., Ltd. Address before: 318020 Huangyan Jiangkou Development Zone, Taizhou, Zhejiang Patentee before: Zhejiang Tianyu Pharmaceutical Co., Ltd. |